drugset / Trial / NCT00433290

Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain

NCT00433290

Phase 3 Completed 256 enrolled Eli Lilly and Company
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with osteoarthritis knee pain.

Timeline

Start
2007-02
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral
Subject Duloxetine Small molecule 120 mg Oral

Indications